Overview

Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia

Status:
Unknown status
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of SLC022 in treating pain associated with post-herpetic neuralgia (PHN) in recently diagnosed patients.
Phase:
Phase 2
Details
Lead Sponsor:
Solace Pharmaceuticals